Meeting
2017 ASCO Annual Meeting
Cost-effectiveness of ovarian cancer screening: An analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) from a U.S. health system perspective.
Authors
Haley Moss
Duke University Medical Center, Durham, NC
Haley Moss , Evan Myers , Andrew Berchuck , Laura Jean Havrilesky
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 35, 2017 (suppl; abstr 6608)
DOI
10.1200/JCO.2017.35.15_suppl.6608
Abstract #
6608
Poster Bd #
430
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Population-based cancer predisposition testing as a component of newborn screening: A cost-effectiveness analysis.
First Author: Jennifer Yeh
Poster
2023 ASCO Annual Meeting
Cost-effectiveness analyses of population-based multi-gene testing for the prevention of breast and ovarian cancer in the United States.
First Author: Fangjian Guo
Poster
2023 ASCO Annual Meeting
The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.
First Author: Chae Young Han
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Cost effectiveness of liquid biopsy for colorectal cancer screening.
First Author: Zainab Aziz